$991 Million is the total value of HARVARD MANAGEMENT CO INC's 44 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 13.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FB | Buy | META PLATFORMS INCcl a | $273,729 | +118.7% | 1,231,019 | +230.8% | 27.63% | +135.2% |
| GOOGL | Buy | ALPHABET INCcap stk cl a | $242,219 | +37.0% | 87,087 | +42.7% | 24.45% | +47.4% |
| SGMS | SCIENTIFIC GAMES CORP | $157,366 | -12.1% | 2,678,571 | 0.0% | 15.88% | -5.5% | |
| ABCL | ABCELLERA BIOLOGICS INC | $40,025 | -31.8% | 4,105,095 | 0.0% | 4.04% | -26.7% | |
| EQRX INC | $21,733 | -39.4% | 5,262,161 | 0.0% | 2.19% | -34.9% | ||
| PCT | Buy | PURECYCLE TECHNOLOGIES INC | $19,985 | +95.2% | 2,498,170 | +133.6% | 2.02% | +109.9% |
| RVMD | REVOLUTION MEDICINES INC | $17,101 | +1.3% | 670,382 | 0.0% | 1.73% | +9.0% | |
| RLAY | RELAY THERAPEUTICS INC | $16,196 | -2.5% | 541,124 | 0.0% | 1.64% | +4.8% | |
| TXG | 10X GENOMICS INC | $14,160 | -48.9% | 186,143 | 0.0% | 1.43% | -45.1% | |
| Buy | GRAB HOLDINGS LIMITEDclass a ord | $12,897 | -9.6% | 3,684,960 | +84.2% | 1.30% | -2.7% | |
| RXRX | RECURSION PHARMACEUTICALS INcl a | $10,806 | -58.2% | 1,509,254 | 0.0% | 1.09% | -55.0% | |
| MELI KASZEK PIONEER CORPclass a ord | $10,280 | -11.1% | 1,000,000 | 0.0% | 1.04% | -4.3% | ||
| FULC | FULCRUM THERAPEUTICS INC | $9,713 | +33.7% | 410,714 | 0.0% | 0.98% | +43.7% | |
| ROCKET LAB USA INC | $8,050 | -34.4% | 1,000,000 | 0.0% | 0.81% | -29.5% | ||
| AFRM | AFFIRM HLDGS INC | $8,032 | -54.0% | 173,560 | 0.0% | 0.81% | -50.5% | |
| MU | MICRON TECHNOLOGY INC | $7,998 | -16.4% | 102,684 | 0.0% | 0.81% | -10.1% | |
| PRAX | PRAXIS PRECISION MEDICINES I | $7,949 | -48.2% | 778,517 | 0.0% | 0.80% | -44.3% | |
| TENAYA THERAPEUTICS INC | $7,931 | -37.8% | 673,270 | 0.0% | 0.80% | -33.1% | ||
| INTC | INTEL CORP | $7,474 | -3.8% | 150,806 | 0.0% | 0.75% | +3.4% | |
| NVDA | NVIDIA CORPORATION | $7,180 | -7.2% | 26,315 | 0.0% | 0.72% | -0.1% | |
| ADI | ANALOG DEVICES INC | $6,894 | -6.0% | 41,739 | 0.0% | 0.70% | +1.0% | |
| LRCX | LAM RESEARCH CORP | $6,731 | -25.2% | 12,521 | 0.0% | 0.68% | -19.6% | |
| TSM | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $6,719 | -13.3% | 64,443 | 0.0% | 0.68% | -6.9% | |
| AMAT | APPLIED MATLS INC | $6,663 | -16.2% | 50,553 | 0.0% | 0.67% | -9.9% | |
| AMD | ADVANCED MICRO DEVICES INC | $5,971 | -24.0% | 54,610 | 0.0% | 0.60% | -18.3% | |
| QRVO | QORVO INC | $5,828 | -20.7% | 46,963 | 0.0% | 0.59% | -14.7% | |
| KNTE | KINNATE BIOPHARMA INC | $5,607 | -36.5% | 498,001 | 0.0% | 0.57% | -31.6% | |
| TANGO THERAPEUTICS INC | $5,370 | -30.7% | 708,385 | 0.0% | 0.54% | -25.4% | ||
| CFLT | CONFLUENT INC | $5,346 | -46.2% | 130,383 | 0.0% | 0.54% | -42.1% | |
| NRIX | NURIX THERAPEUTICS INC | $4,410 | -51.6% | 314,762 | 0.0% | 0.44% | -48.0% | |
| PLRX | PLIANT THERAPEUTICS INC | $3,942 | -48.1% | 562,379 | 0.0% | 0.40% | -44.2% | |
| SANA | SANA BIOTECHNOLOGY INC | $3,872 | -46.6% | 468,749 | 0.0% | 0.39% | -42.6% | |
| GBIO | GENERATION BIO CO | $3,746 | +3.7% | 510,354 | 0.0% | 0.38% | +11.5% | |
| XILIO THERAPEUTICS INC | $2,942 | -55.8% | 416,059 | 0.0% | 0.30% | -52.5% | ||
| PARDES BIOSCIENCES INC | $2,888 | -55.9% | 400,000 | 0.0% | 0.29% | -52.5% | ||
| SURROZEN INC | $2,489 | -53.3% | 826,852 | 0.0% | 0.25% | -49.8% | ||
| PACB | PACIFIC BIOSCIENCES CALIF IN | $2,085 | -55.5% | 229,144 | 0.0% | 0.21% | -52.3% | |
| PCTTW | New | PURECYCLE TECHNOLOGIES INC*w exp 03/17/202 | $2,050 | – | 714,285 | +100.0% | 0.21% | – |
| New | VIGIL NEUROSCIENCE INC | $2,035 | – | 289,460 | +100.0% | 0.20% | – | |
| DYN | DYNE THERAPEUTICS INC | $1,034 | -18.9% | 107,252 | 0.0% | 0.10% | -13.3% | |
| DBTX | DECIBEL THERAPEUTICS INC | $1,000 | -34.6% | 328,798 | 0.0% | 0.10% | -29.9% | |
| MGTA | MAGENTA THERAPEUTICS INC | $965 | -34.5% | 332,610 | 0.0% | 0.10% | -29.7% | |
| MCRB | SERES THERAPEUTICS INC | $939 | -14.5% | 131,847 | 0.0% | 0.10% | -7.8% | |
| GMTX | GEMINI THERAPEUTICS INC | $348 | -52.2% | 250,000 | 0.0% | 0.04% | -48.5% | |
| Exit | SURROZEN INC*w exp 08/01/203 | $0 | – | -108,333 | -100.0% | -0.01% | – | |
| DADA | Exit | DADA NEXUS LTDads | $0 | – | -40,338 | -100.0% | -0.05% | – |
| ASML | Exit | ASML HOLDING N V | $0 | – | -9,034 | -100.0% | -0.68% | – |
| RPRX | Exit | ROYALTY PHARMA PLC | $0 | – | -3,464,990 | -100.0% | -12.96% | – |
These EDGAR filings were analyzed to create this holdings report:
The EDGAR filing(s) were signed by:
- Kathryn I. Murtagh — Managing Director - Chief Compliance Officer
- HARVARD MANAGEMENT CO INC holdings (13F-HR)
- HARVARD MANAGEMENT CO INC significant holdings (13D/G)
- HARVARD MANAGEMENT CO INC ownership history
- HARVARD MANAGEMENT CO INC portfolio value
- HARVARD MANAGEMENT CO INC filings
- Similar filers BETA
Compare quarterly holdings
Export HARVARD MANAGEMENT CO INC's holdings